Global Information would like to present a new market research report, "Molecular Diagnostics - Technologies, Markets and Companies" by Jain Pharmabiotech.
Molecular diagnostics technologies includes: several polymerase chain reaction (PCR)-based technologies, fluorescent in situ hybridization (FISH), peptide nucleic acids (PNA), electrochemical detection of DNA, biochips, nanotechnology and proteomic technologies. Jain Pharmabiotechs report describes and evaluates the molecular diagnostics technologies that will play a central role in the medical practice, pharmaceutical industry, public health, forensics and biological warfare in the 21st century.
The number of companies involved in molecular diagnostics has risen dramatically in the past few years. Most of the molecular diagnostics developments have occurred in the U.S., which is also home to the largest number of companies.
This report includes significant information that may be of importance for: molecular diagnostic company CEOs; officers of genomic and proteomic companies interested in diagnostic technologies; business development executives of biotechnology and pharmaceutical companies; healthcare service planners; research scientists; and executives of companies involved in developing integration of diagnosis and treatment as well as those interested in personalized medicine.